Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on May 22, 2025

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare the safety and efficacy of two dose levels of Purified …

CorVel Announces Revenues and Earnings
FORT WORTH, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2025. Revenues for the quarter were $232 million, an increase from $207 million in the March quarter …

Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 (‘2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results…
Phase 3 trial of ‘2510 in combination with chemotherapy in first-line NSCLC anticipated to start in mid-2026 in China, subject to regulatory discussions Monotherapy US dose optimization Phase 1b/2 trial of ‘2510 in relapsed/refractory solid tumors, …

Global Health Leaders Convene at WHA78 Side Event to Advocate for Steatotic Liver Disease as a Core Non-Communicable Disease
Geneva, Switzerland, May 22, 2025 (GLOBE NEWSWIRE) -- Leading health organizations, policymakers, and public health advocates will come together during the 78th World Health Assembly (WHA78) for a pivotal side event titled “Together for Better Liver Health …

LIfT BioSciences presents preclinical data on its first-in-class Immunomodulatory Alpha Neutrophils at American Society of Gene & Cell Therapy 28th Annual Meeting, showcasing its versatility in diseases beyond oncology
London, 22 May 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today announces that preclinical data showing the wider therapeutic potential of its first-in-class …

CheqUp and WeightWatchers Announce Strategic Partnership to Support Growing Use of GLP-1 Medications in the UK
CHIPPENHAM, England, May 22, 2025 (GLOBE NEWSWIRE) -- CheqUp, one of the UK’s leading providers of GLP-1 based weight loss services, and WeightWatchers, the global leader in science-backed weight management, have announced a partnership that will combine …

Clue Reaches 1 Million Paid Subscribers, Cementing Position as Leading Data-Driven Women's Health Intelligence Platform
BERLIN, May 22, 2025 (GLOBE NEWSWIRE) -- Clue, the data-driven women's health intelligence platform, today announced it has reached 1 million paid subscribers, more than doubling its subscriber base in just over a year. This milestone comes amid explosive …